India’s pharmaceutical are still on a roll: pharma exports to the US jumped 14 % in April–Feb FY25, touching US $9.8 billion even off a hefty base, Pharmexcil data shows.
- America still rules the prescription pad—it soaks up 36.6 % of all Indian pharma shipments.
- Global lift : Overall pharma exports rose 7 % to US $26.8 billion, putting the full‑year tally on track for ~US $27 billion.
- Risk radar : With talk of fresh US import tariffs, Indian manufacturers are scouting new frontiers in Europe, Africa, and emerging markets to keep growth humming.
Logistics lens : Expect steady volumes of time‑sensitive, high‑value pharma freight heading west—plus a pivot toward alternative lanes as exporters hedge against tariff risk. Tighten your cold‑chain and compliance game to stay ahead.